(2R,3R,4S,5R,2'R,3'R,4'S,5'S)-2,2'-{TRANS-1,4-CICLOHEXANODIILBIS-[IMINO(2-{[2-(1-METIL-1H-IMIDAZOL-4-IL)ETIL]AMINO}-9H-PURIN-6,9-DIIL)]}BIS[5-(2-ETIL-2H-TETRAZOL-5-IL)TETRAHIDRO-3,4-FURANODIOL] COMO AGONISTA A2A

SE REFIERE A SALES Y SOLVATOS DE (2R,3R,4S,5R,2'R,3'R,4'S,5'S)-2,2'-{TRANS-1,4-CICLOHEXANODIILBIS-[IMINO(2-{[2-(1-METIL-1H-IMIDAZOL-4-IL)ETIL]AMINO}-9H-PURIN-6,9-DIIL)]}BIS[5-(2-ETIL-2H-TETRAZOL-5-IL)TETRAHIDRO-3,4-FURANODIOL] Y UN PROCEDIMIENTO DE PREPARACION. SE REFIERE TA...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BLATCHER PHILIP, COUSINS RICHARD PETER CHARLES, EVANS DEREK NORMAN
Format: Patent
Sprache:spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:SE REFIERE A SALES Y SOLVATOS DE (2R,3R,4S,5R,2'R,3'R,4'S,5'S)-2,2'-{TRANS-1,4-CICLOHEXANODIILBIS-[IMINO(2-{[2-(1-METIL-1H-IMIDAZOL-4-IL)ETIL]AMINO}-9H-PURIN-6,9-DIIL)]}BIS[5-(2-ETIL-2H-TETRAZOL-5-IL)TETRAHIDRO-3,4-FURANODIOL] Y UN PROCEDIMIENTO DE PREPARACION. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. DICHO COMPUESTO ES AGONISTA POTENTE DEL RECEPTOR DE ADENOSINA A2A, UTIL EN EL TRATAMIENTO DE ENFERMEDADES INFLAMATORIAS TALES COMO ASMA Y ENFERMEDAD PULMONAR OBSTRUCTIVA CRONICA A compound of formula (I) and salts and solvates thereof are disclosed. Compounds of formula (I) are agonists of the adenosine A2A receptor and are believed to be of potential use in the treatment of inflammatory diseases such as asthma and chronic obstructive pulmonary disease.